10/31/2024
4:20 PM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/28/2024
7:15 AM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2024
3:36 PM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2024
3:15 PM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
3:48 PM | Evofem Biosciences (Filer)
| Form PRE 14A | |
08/30/2024
4:04 PM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/21/2024
11:11 AM | Evofem Biosciences (Filer)
| Form D
Notice of Exempt Offering of Securities | |
|
08/14/2024
6:00 AM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
6:05 AM | Evofem Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/23/2024
3:30 PM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
3:35 PM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
3:30 PM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/18/2024
7:15 AM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
3:46 PM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/15/2024
5:45 AM | Evofem Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2024
5:50 AM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
4:28 PM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
7:36 AM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
7:40 AM | Evofem Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2024
4:14 PM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
1:14 PM | CVI Investments, Inc. (Filed by)
Evofem Biosciences (Subject)
| Form SC 13G/A | |
02/01/2024
8:05 AM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
3:26 PM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/12/2024
4:13 PM | Evofem Biosciences (Issuer)
Zhang Yan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:53 PM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/22/2023
3:05 PM | Evofem Biosciences (Issuer)
Kamdar Kim P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:17 PM | Evofem Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Free EVFM Stock Alerts